Inhibitors of cellular kinases with broad-spectrum antiviral activity for hemorrhagic fever viruses

Antiviral Research

Volumn 120, Issue , 2015, Pages 40-47

  Mohr, Emma L ^a,b   McMullan, Laura K ^a   Lo, Michael K ^a   Spengler, Jessica R ^a   Bergeron, Éric ^a   Albariño, César G ^a   Shrivastava Ranjan, Punya ^a   Chiang, Cheng Feng ^a   Nichol, Stuart T ^a   Spiropoulou, Christina F ^a   Flint, Mike ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antiviral; AR 12; BIBX; Ebola; Lassa

Indexed keywords

FALNIDAMOL; PHOSPHOTRANSFERASE INHIBITOR; VIRUS GLYCOPROTEIN; ANTIVIRUS AGENT; PHOSPHOTRANSFERASE;

ANTIVIRAL ACTIVITY; APOPTOSIS; ARTICLE; CELL LYSATE; CELL VIABILITY; CONTROLLED STUDY; EBOLA HEMORRHAGIC FEVER; FEMALE; HOST CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MARBURGVIRUS; NIPAH VIRUS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS CELL INTERACTION; VIRUS HEMORRHAGIC FEVER; WILD TYPE; ANIMAL; ANTAGONISTS AND INHIBITORS; ARENAVIRIDAE; CELL LINE; DRUG EFFECTS; FILOVIRIDAE; METABOLISM; PHYSIOLOGY; VIRUS ENTRY; VIRUS REPLICATION;

EBOLA VIRUS; LAKE VICTORIA MARBURGVIRUS; NIPAH VIRUS;

ANIMALS; ANTIVIRAL AGENTS; ARENAVIRIDAE; CELL LINE; FILOVIRIDAE; HUMANS; NIPAH VIRUS; PHOSPHOTRANSFERASES; VIRUS INTERNALIZATION; VIRUS REPLICATION;

EID: 84930213056     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2015.05.003     Document Type: Article

References (37)

1. C.G. Albariño, L.S. Uebelhoer, J.P. Vincent, M.L. Khristova, A.K. Chakrabarti, A. McElroy, S.T. Nichol, and J.S. Towner Development of a reverse genetics system to generate recombinant Marburg virus derived from a bat isolate Virology 446 2013 230 237
2. M. Aljofan Hendra and Nipah infection: emerging paramyxoviruses Virus Res. 177 2013 119 126
3. L. Booth, J.L. Roberts, D.R. Cash, S. Tavallai, S. Jean, A. Fidanza, T. Cruz-Luna, P. Siembiba, K.A. Cycon, C.N. Cornelissen, and P. Dent GRP78/BiP/HSPA5/Dna K is a universal therapeutic target for human disease J. Cell. Physiol. 230 2015 1661 1676
4. J.E. Carette, M. Raaben, A.C. Wong, A.S. Herbert, G. Obernosterer, N. Mulherkar, A.I. Kuehne, P.J. Kranzusch, A.M. Griffin, G. Ruthel, P. Dal Cin, J.M. Dye, S.P. Whelan, K. Chandran, and T.R. Brummelkamp Ebola virus entry requires the cholesterol transporter Niemann-Pick C1 Nature 477 2011 340 343
5. M. Cote, J. Misasi, T. Ren, A. Bruchez, K. Lee, C.M. Filone, L. Hensley, Q. Li, D. Ory, K. Chandran, and J. Cunningham Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection Nature 477 2011 344 348
6. C. Dittrich, G. Greim, M. Borner, K. Weigang-Kohler, H. Huisman, A. Amelsberg, A. Ehret, J. Wanders, A. Hanauske, and P. Fumoleau Phase I and pharmacokinetic study of BIBX 1382 BS, an epidermal growth factor receptor (EGFR) inhibitor, given in a continuous daily oral administration Eur. J. Cancer 38 2002 1072 1080
7. M. Egeblad, O.H. Mortensen, L.C. van Kempen, and M. Jaattela BIBX1382BS, but not AG1478 or PD153035, inhibits the ErbB kinases at different concentrations in intact cells Biochem. Biophys. Res. Commun. 281 2001 25 31
8. M. Flint, C. Logvinoff, C.M. Rice, and J.A. McKeating Characterization of infectious retroviral pseudotype particles bearing hepatitis C virus glycoproteins J. Virol. 78 2004 6875 6882
9. M. Flint, L.K. McMullan, K.A. Dodd, B.H. Bird, M.L. Khristova, S.T. Nichol, and C.F. Spiropoulou Inhibitors of the tick-borne, hemorrhagic fever-associated flaviviruses Antimicrob. Agents Chemother. 58 2014 3206 3216
10. M. Gao, P.Y. Yeh, Y.S. Lu, C.H. Hsu, K.F. Chen, W.C. Lee, W.C. Feng, C.S. Chen, M.L. Kuo, and A.L. Cheng OSU-03012, a novel celecoxib derivative, induces reactive oxygen species-related autophagy in hepatocellular carcinoma Cancer Res. 68 2008 9348 9357
11. G. Gehring, K. Rohrmann, N. Atenchong, E. Mittler, S. Becker, F. Dahlmann, S. Pohlmann, F.W. Vondran, S. David, M.P. Manns, S. Ciesek, and T. von Hahn The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry J. Antimicrob. Chemother. 69 2014 2123 2131
12. L.T. Jae, M. Raaben, A.S. Herbert, A.I. Kuehne, A.S. Wirchnianski, T.K. Soh, S.H. Stubbs, H. Janssen, M. Damme, P. Saftig, S.P. Whelan, J.M. Dye, and T.R. Brummelkamp Virus entry. Lassa virus entry requires a trigger-induced receptor switch Science 344 2014 1506 1510
13. A.J. Johnson, L.L. Smith, J. Zhu, N.A. Heerema, S. Jefferson, A. Mone, M. Grever, C.S. Chen, and J.C. Byrd A novel celecoxib derivative, OSU03012, induces cytotoxicity in primary CLL cells and transformed B-cell lymphoma cell line via a caspase- and Bcl-2-independent mechanism Blood 105 2005 2504 2509
14. J. Kortekaas, O. Ergonul, and R.J. Moormann Interventions against West Nile virus, Rift Valley fever virus, and Crimean-Congo hemorrhagic fever virus: where are we? Vector Borne Zoonotic Dis. 10 2010 709 718
15. T.X. Lee, M.D. Packer, J. Huang, E.M. Akhmametyeva, S.K. Kulp, C.S. Chen, M. Giovannini, A. Jacob, D.B. Welling, and L.S. Chang Growth inhibitory and anti-tumour activities of OSU-03012, a novel PDK-1 inhibitor, on vestibular schwannoma and malignant schwannoma cells Eur. J. Cancer 45 2009 1709 1720
16. F.N. Linero, and L.A. Scolaro Participation of the phosphatidylinositol 3-kinase/Akt pathway in Junin virus replication in vitro Virus Res. 145 2009 166 170
17. J. Liu, C.K. Qin, W. Lv, Q. Zhao, and C.Y. Qin OSU-03012, a non-Cox inhibiting celecoxib derivative, induces apoptosis of human esophageal carcinoma cells through a p53/Bax/cytochrome c/caspase-9-dependent pathway Anticancer Drugs 24 2013 690 698
18. M.K. Lo, S.T. Nichol, and C.F. Spiropoulou Evaluation of luciferase and GFP-expressing Nipah viruses for rapid quantitative antiviral screening Antiviral Res. 106 2014 53 60
19. A. MacNeil, and P.E. Rollin Ebola and Marburg hemorrhagic fevers: neglected tropical diseases? PLoS Negl. Trop. Dis. 6 2012 e1546
20. T.A. Madani Alkhurma virus infection, a new viral hemorrhagic fever in Saudi Arabia J. Infect. 51 2005 91 97
21. S. McNulty, M. Flint, S.T. Nichol, and C.F. Spiropoulou Host mTORC1 signaling regulates andes virus replication J. Virol. 87 2013 912 922
22. A. Nanbo, M. Imai, S. Watanabe, T. Noda, K. Takahashi, G. Neumann, P. Halfmann, and Y. Kawaoka Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner PLoS Pathog. 6 2010 e1001121
23. O. Ogbu, E. Ajuluchukwu, and C.J. Uneke Lassa fever in West African sub-region: an overview J. Vector Borne Dis. 44 2007 1 11
24. J. Paragas, C.A. Whitehouse, T.P. Endy, and M. Bray A simple assay for determining antiviral activity against Crimean-Congo hemorrhagic fever virus Antiviral Res. 62 2004 21 25
25. M. Perez, R.C. Craven, and J.C. de la Torre The small RING finger protein Z drives arenavirus budding: implications for antiviral strategies Proc. Natl. Acad. Sci. USA 100 2003 12978 12983
26. M. Perez, D.L. Greenwald, and J.C. de la Torre Myristoylation of the RING finger Z protein is essential for arenavirus budding J. Virol. 78 2004 11443 11448
27. L.M. Porchia, M. Guerra, Y.C. Wang, Y. Zhang, A.V. Espinosa, M. Shinohara, S.K. Kulp, L.S. Kirschner, M. Saji, C.S. Chen, and M.D. Ringel 2-amino-N-{4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-phenyl} acetamide (OSU-03012), a celecoxib derivative, directly targets p21-activated kinase Mol. Pharmacol. 72 2007 1124 1131
28. L.J. Reed, and H. Muench A simple method of estimating fifty per cent endpoints Am. J. Hyg. 27 1938 493 497
29. S.P. Reid, A.C. Shurtleff, J.A. Costantino, S.R. Tritsch, C. Retterer, K.B. Spurgers, and S. Bavari HSPA5 is an essential host factor for Ebola virus infection Antiviral Res. 109 2014 171 174
30. M.F. Saeed, A.A. Kolokoltsov, T. Albrecht, and R.A. Davey Cellular entry of Ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes PLoS Pathog. 6 2010 e1001110
31. M.F. Saeed, A.A. Kolokoltsov, A.N. Freiberg, M.R. Holbrook, and R.A. Davey Phosphoinositide-3 kinase-Akt pathway controls cellular entry of Ebola virus PLoS Pathog. 4 2008 e1000141
32. K.B. Spurgers, T. Alefantis, B.D. Peyser, G.T. Ruthel, A.A. Bergeron, J.A. Costantino, S. Enterlein, K.P. Kota, R.C. Boltz, M.J. Aman, V.G. Delvecchio, and S. Bavari Identification of essential filovirion-associated host factors by serial proteomic analysis and RNAi screen Mol. Cell. Proteomics 9 2010 2690 2703
33. T. Strecker, R. Eichler, J. Meulen, W. Weissenhorn, H. Dieter Klenk, W. Garten, and O. Lenz Lassa virus Z protein is a matrix protein and sufficient for the release of virus-like particles [corrected] J. Virol. 77 2003 10700 10705
34. J.S. Towner, J. Paragas, J.E. Dover, M. Gupta, C.S. Goldsmith, J.W. Huggins, and S.T. Nichol Generation of eGFP expressing recombinant Zaire Ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening Virology 332 2005 20 27
35. S. Urata, N. Ngo, and J.C. de la Torre The PI3K/Akt pathway contributes to arenavirus budding J. Virol. 86 2012 4578 4585
36. E.M. Vela, L. Zhang, T.M. Colpitts, R.A. Davey, and J.F. Aronson Arenavirus entry occurs through a cholesterol-dependent, non-caveolar, clathrin-mediated endocytic mechanism Virology 369 2007 1 11
37. J. Zhu, J.W. Huang, P.H. Tseng, Y.T. Yang, J. Fowble, C.W. Shiau, Y.J. Shaw, S.K. Kulp, and C.S. Chen From the cyclooxygenase-2 inhibitor celecoxib to a novel class of 3-phosphoinositide-dependent protein kinase-1 inhibitors Cancer Res. 64 2004 4309 4318